Emnar Pharma was established in 2005. We are leading manufacturers of high-quality generic Active Pharmaceutical Ingredients (APIs), based in Hyderabad, India. We are a part of the Virchow Group of Companies. We are dedicated to providing affordable, reliable, and globally compliant APIs to pharmaceutical companies around the world. With a focus on scalable production, regulatory precision, and deep scientific expertise, we support partners in both regulated and semi-regulated markets.

Our Vizag Unit 2 API Facility is approved by major global regulatory agencies, including the USFDA, WHO-GMP EDQM, and KFDA. These certifications are a testament to our commitment to quality, safety, and adherence to international manufacturing standards. Additionally, our compliance with CDSCO and other Indian regulatory bodies ensures transparency and efficiency in domestic operations.

At Emnar, we emphasise cost-effective process development, route-of-synthesis optimisation, and strict impurity profiling, backed by a strong R&D and analytical team. Our API portfolio spans multiple therapeutic segments, and we actively file Drug Master Files (DMFs) to support regulatory submissions for our partners.

From laboratory-scale innovation to full-scale commercial production, Emnar Pharma is built to serve your API needs with integrity, speed, and reliability.